StockMarketWire.com - Barclays Capital today reaffirms its underweight investment rating on Spire Healthcare Group [LON:SPI] and cut its price target to 115p (from 130p).

Story provided by StockMarketWire.com

Broker Forecasts data provided by www.sharesmagazine.co.uk